Amal Al-Naimi

Amal Al-Naimi MBBS

Senior Attending Physician Years Of Experience: 10
  • About Amal

    Dr. Amal Al Naimi was Arab Board certified in pediatrics in 2008. She completed her fellowship in pediatric pulmonology in 2009 at Hamad Medical Corporation (HMC) and pediatric respirology fellowship in 2011 at Hospital for Sick Children, Toronto Canada.
    Dr. Amal is a senior attending pediatric pulmonology at Sidra Medicine and an assistant professor in clinical pediatrics at Weill-Cornell Medical College in Qatar (WCMC-Q).
    Dr Amal has been privileged to teach, train, and mentor medical students, pediatric residents, and pediatric pulmonology fellows.
    Dr. Amal has a particular interest in the area of Cystic Fibrosis, Pediatric NIV and Chest NMD.
    Dr. Amal Al Naimi has led and participated in numerous research projects and published many peer-reviewed articles in pediatric pulmonology medicine. Her current research focuses on pulmonary outcomes in SMA patients post gene therapy and chronic non-invasive ventilation in pediatrics.
    Besides her clinical and academic commitments, Amal holds several key positions in Sidra Medicine. She is the Director of Pediatric Cystic Fibrosis and leads the Pediatric NIV and chest NMD Program.

    Languages Spoken

    English, Arabic

    Years Of Experience
    • MBBS
      King Faisal University, College of Medicine and Medical Sciences
      Dammam, Kingdom of Saudi Arabia
    • Assistant Professor in Clinical Pediatrics at Weill-Cornell Medical College in Qatar (WCMC-Q)
    Areas of Interest
    • Cystic Fibrosis
    • Pediatric NIV
    • Chest NMD Program
    Medical Publications (Only 5 publications max from past 5 years)
    1. The prevalence of asthma, allergic rhinitis, and eczema among school-aged children in Qatar: A Global Asthma Network Study, PMID: 35362672
    2. Tracheal Bronchus and Associated Anomaly Prevalence Among Children, PMID:34178512
    3. A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes, PMID:34427831
    4. Pleuropulmonary Blastoma (PPB) in Child with DICER1 Mutation: The First Case Report in the State of Qatar, PMID: 34745680
    5. First report of the cystic fibrosis transmembrane conductance regulator mutation c.1521_1523delCTT (p. Phe508del) in two Qatari patients with cystic fibrosis, PMID: 34377682